RA CAPITAL MANAGEMENT, L.P. Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$1.7T
Holdings
25
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,512,049 | $315.8B | 18.38% | |
| 2 | ASNDASCENDIS PHARMA A S | 4,240,536 | $265.7B | 15.46% | |
| 3 | —SYNTHORX INC | 9,724,598 | $169.0B | 9.84% | |
| 4 | —ZOGENIX INC | 2,382,168 | $86.9B | 5.06% | |
| 5 | BCRXBIOCRYST PHARMACEUTICALS | 10,660,349 | $86.0B | 5.01% | |
| 6 | ORTXUSDORCHARD THERAPEUTICS PLC | 4,845,933 | $76.2B | 4.44% | |
| 7 | IFRXINFLARX NV | 2,085,089 | $75.8B | 4.41% | |
| 8 | SLDBSOLID BIOSCIENCES INC | 2,689,444 | $72.1B | 4.20% | |
| 9 | —MYOVANT SCIENCES LTD | 3,711,549 | $60.9B | 3.55% | |
| 10 | —EIDOS THERAPEUTICS INC | 2,162,671 | $59.2B | 3.45% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS INC | 1,875,209 | $56.2B | 3.27% | |
| 12 | RYTMRHYTHM PHARMACEUTICALS INC | 1,950,332 | $52.4B | 3.05% | |
| 13 | —IMMUNOMEDICS INC | 3,021,466 | $43.1B | 2.51% | |
| 14 | ARVNARVINAS INC | 3,138,412 | $40.3B | 2.35% | |
| 15 | —RA PHARMACEUTICALS INC | 4,858,260 | $34.0B | 1.98% | |
| 16 | TGTXTG THERAPEUTICS INC | 8,198,337 | $33.6B | 1.96% | |
| 17 | KALVKALVISTA PHARMACEUTICALS INC | 1,441,070 | $28.5B | 1.66% | |
| 18 | —MOMENTA PHARMACEUTICALS INC | 2,558,357 | $28.2B | 1.64% | |
| 19 | —DICERNA PHARMACEUTICALS INC | 2,456,669 | $26.3B | 1.53% | |
| 20 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 2,415,458 | $24.5B | 1.43% | |
| 21 | IOVAIOVANCE BIOTHERAPEUTICS INC | 2,720,452 | $24.1B | 1.40% | |
| 22 | MRNAMODERNA INC | 1,514,326 | $23.1B | 1.35% | |
| 23 | KALAKALA PHARMACEUTICALS INC | 4,537,478 | $22.2B | 1.29% | |
| 24 | SCPHSCPHARMACEUTICALS INC | 2,857,143 | $10.7B | 0.63% | |
| 25 | —PROTEON THERAPEUTICS INC | 1,337,462 | $3.0B | 0.18% |